Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer by Wenbo Qi, Wenbo Qi, Wenbo Qi, Dayong Xi, Dayong Xi, Dayong Xi, Yuping Bai, Yuping Bai, Yuping Bai, Le Liu, Le Liu, Le Liu, Yanling Ma, Yanling Ma, Yanling Ma, Zhenyu Yin, Zhenyu Yin, Zhenyu Yin, Hao Chen, Hao Chen

Connect to this object online.